James Longden
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
James Longden has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
Jesper Ferkinghoff-Borg
Biotech Research & Innovation Centre, University of Copenhagen, Copenhagen, 2200, Denmark
2 shared publicationsMathias Engel
Biotech Research & Innovation Centre, University of Copenhagen, Copenhagen, 2200, Denmark; Niels Bohr Institute, University of Copenhagen, Copenhagen, 2200, Denmark
2 shared publications- Rune Linding
Humboldt-Universitaet zu Berlin
2 shared publications Xavier Robin
Biotech Research & Innovation Centre, University of Copenhagen, Copenhagen, 2200, Denmark
2 shared publicationsConor Howard
University of Copenhagen
1 shared publicationCraig D. Simpson
University of Copenhagen
1 shared publication
Latest Publications
- Open Access
- 1 January 2021
- Published by Elsevier in Cell Reports
- Vol. 34 (3) , 108657
Deep neural networks identify signaling mechanisms of ErbB-family drug resistance from a continuous cell morphology space
- 1 January 2021
- Published by Elsevier in Cell Reports
- Vol. 34 (3) , 108657
Open AccessDeep neural networks identify signaling mechanisms of ErbB-family drug resistance from a continuous cell morphology space
- Open Access
Probability-based detection of phosphoproteomic uncertainty reveals rare signaling events driven by oncogenic kinase gene fusion
We describe a novel Bayesian method for estimating protein concentration and phosphorylation site occupancy ratios from mass spectrometry experiments. Our variance model assigns standard deviations to all quantitative ratios, even when only a single peptide is observed, increasing the number of quantifiable observations in a sample compared to conventional methods. We further demonstrate the application of this method using a dataset investigating the impact of the PRKAR1A-RET gene fusion in immortalized thyroid cells.
Open AccessProbability-based detection of phosphoproteomic uncertainty reveals rare signaling events driven by oncogenic kinase gene fusion
We describe a novel Bayesian method for estimating protein concentration and phosphorylation site occupancy ratios from mass spectrometry experiments. Our variance model assigns standard deviations to all quantitative ratios, even when only a single peptide is observed, increasing the number of quantifiable observations in a sample compared to conventional methods. We further demonstrate the application of this method using a dataset investigating the impact of the PRKAR1A-RET gene fusion in immortalized thyroid cells.